NPI registry status
Active
2026 NPPES data Pediatric Nephrology Physician NPI 1174550156 MD
Verify on CMS → Jayanthi Chandar, MD
Pediatric Nephrology Physician in Miami, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 724 in Pediatric Nephrology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
176
Medicare Part D claims · 26 beneficiaries · Pediatric Nephrology Physician avg: 97
Generic prescribing
76%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.3/100
▼ 2 pts below national avg 83.1 · Above neutral
Industry payments
$88.32
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Jayanthi Chandar, MD reported a CMS MIPS final score of 81.3/100 - below the 83.1 national average - and filed 176 Medicare Part D claims in 2023.
- 81.3/100
- MIPS score · -2 vs avg
- 176
- Part D claims, 2023
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Jayanthi Chandar, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
81 36th percentile higher than 36% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Jayanthi Chandar, MD sits
This provider among pediatric nephrology physician peers
Across the 80 pediatric nephrology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Jayanthi Chandar, MD writes more Part D claims than 85% of them and scores higher on MIPS quality than 39% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pediatric nephrology physician peer from a representative sample of 60; the gold marker is Jayanthi Chandar, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Jayanthi Chandar, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Jayanthi Chandar, MD?
Near national averagePrimary specialty
Pediatric Nephrology Physician
Medicare Part D claims
176 81% vs specialty avg
MIPS final score
81.3/100 1.8 pts vs avg
Specialty distribution in Florida
How Pediatric Nephrology Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Jayanthi Chandar, MD's 2023 MIPS final score plotted against the Pediatric Nephrology Physician national average
- MIPS Final Score
- 81.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Nephrology Physician) - 81.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Jayanthi Chandar, MD appears in the CMS NPPES registry as a Pediatric Nephrology Physician provider holding MD credentials at 1601 NW 12TH AVE, Miami, FL, 33101, with a listed phone of (305) 585-6726. NPI 1174550156 was issued on 06/27/2006.
Medicare Part D records for calendar year 2023 show 176 prescription claims written by this provider, covering 26 Medicare beneficiaries and totaling roughly $72K in drug spend, split 16% brand-name and 76% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.3/100 for the 2023 performance year (Quality 78.5, Cost 50.6), compared with the national average of 83.1.
Pediatric Nephrology Physician is a narrow specialty nationwide, with 724 enrolled providers across 50 states and an average of 97 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174550156 |
|---|---|
| Specialty | Pediatric Nephrology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/27/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
81.3101
Final Score
Avg: 83.1
78.455
Quality
50.5984
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Jayanthi Chandar, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Miami
Miami, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jayanthi Chandar, MD. Source: openpaymentsdata.cms.gov.
Total received
$88
Largest payer
CALLIDITAS THERAPEUTICS US INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Jayanthi Chandar, MD. To verify Jayanthi Chandar, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Jayanthi Chandar, MD - brand share 16.0%
Pediatric Nephrology Physician average
16% brand-name claims vs 76% generic, on 176 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
176
Total Claims
$72K
Total Drug Cost
26
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 358
- Total Day Supply
- 10,601
- Brand vs Generic
- 16% brand / 76% generic
- Brand Drug Cost
- $45K
- Generic Drug Cost
- $27K
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 15.5 years
- Avg HCC Risk Score
- 6.14
- Age Distribution
- <65: 26, 65-74: 0, 75-84: 0, 85+: 0
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Jayanthi Chandar, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Sodium Polystyrene…
Sodium Polystyrene Sulfonate
34 claims
- Famotidine
Famotidine
16 claims
- Sulfamethoxazole-T…
Sulfamethoxazole-Trimethoprim
15 claims
- Procrit 12
Procrit
12 claims
- Candesartan Cilexe… 11
Candesartan Cilexetil
11 claims
| Drug | Claims |
|---|---|
| Sodium Polystyrene Sulfonate | 34 |
| Famotidine | 16 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 |
| Procrit Epoetin Alfa | 12 |
| Candesartan Cilexetil | 11 |
| Insulin Syringe "Syringe And Needle | N/A |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Nephrology Physician Overview
How Jayanthi Chandar, MD fits within the Pediatric Nephrology Physician landscape nationally.
724
Pediatric Nephrology Physician Providers in US
50
States with Pediatric Nephrology Physician
97
Avg Claims per Provider
Jayanthi Chandar, MD's 176 claims are above the specialty average of 97.
Nearby Pediatric Nephrology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Chandar.
Dr. Carolyn Abitbol
MD
Miami, FL
Dr. Eihab Alkhasawneh
M.D.
Gainesville, FL
Dr. Carlos Araya
MD
Orlando, FL
Dr. Aura Arenas Morales
M.D.
Orlando, FL
Dr. Ashraf Awad
MD
Gainesville, FL
Compare Pediatric Nephrology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Nephrology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Jayanthi Chandar, MD's specialty? ▼
Jayanthi Chandar, MD specializes in Pediatric Nephrology Physician and practices in Miami, Florida. Credentials: MD.
How much does Jayanthi Chandar, MD prescribe under Medicare Part D? ▼
In 2023, Jayanthi Chandar, MD wrote 176 Medicare Part D claims totaling $72K in drug costs for 26 beneficiaries.
What is Jayanthi Chandar, MD's Medicare quality score? ▼
Jayanthi Chandar, MD has a CMS MIPS Final Score of 81.3/100 (Quality: 78.5, Cost: 50.6). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Jayanthi Chandar, MD located? ▼
Jayanthi Chandar, MD is located at 1601 NW 12TH AVE, Miami, FL, 33101. Phone: (305) 585-6726.
What is Jayanthi Chandar, MD's NPI number? ▼
Jayanthi Chandar, MD's National Provider Identifier (NPI) is 1174550156, issued on 06/27/2006.
Does Jayanthi Chandar, MD prescribe more brand-name or generic drugs? ▼
Jayanthi Chandar, MD's prescribing is 16% brand-name and 76% generic drugs by claim count, with $45K in brand drug costs.
How many Pediatric Nephrology Physician providers are there in the US? ▼
There are 724 Pediatric Nephrology Physician providers across 50 states in the US. The average Pediatric Nephrology Physician provider writes 97 Medicare Part D claims per year.
What drugs does Jayanthi Chandar, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Jayanthi Chandar, MD's most frequently prescribed drugs include Sodium Polystyrene Sulfonate, Famotidine, Sulfamethoxazole-Trimethoprim. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jayanthi Chandar, MD accept Medicare? ▼
Jayanthi Chandar, MD appears in CMS Medicare data with 176 Part D claims and 26 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jayanthi Chandar, MD's credentials? ▼
Jayanthi Chandar, MD's NPI is 1174550156 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.